Search results for "Hepatocellular carcinoma"


 
Results 31 - 36 of about 36 for "Hepatocellular carcinoma".
Sort by: Relevance | Newest | Oldest

Spotlight on HCV screening

New guidance from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America recommended universal hepatitis C virus (HCV) screening for all adults, and two recent studies reported on interventions that improved HCV screening and care in baby boomers.
https://gastroenterology.acponline.org/archives/2019/12/27/5.htm
27 Dec 2019

Spotlight on hepatitis A, B, and C

The past month's gastroenterology research may not have been simple as ABC, but it did focus on the major types of hepatitis, including a hepatitis A outbreak, a comparison of hepatitis B drugs, and new data on hepatitis C complications and incidence.
https://gastroenterology.acponline.org/archives/2019/10/25/5.htm
25 Oct 2019

Spotlight on new guidelines

The American Association for the Study of Liver Diseases, the American Gastroenterological Association, the American College of Gastroenterology, and the U.S. Preventive Services Task Force all released new guidelines this month.
https://gastroenterology.acponline.org/archives/2019/07/26/5.htm
26 Jul 2019

High HCV cure rate seen with FDA-approved direct-acting antiviral regimens

Six of the direct-acting antiviral (DAA) regimens yielded sustained virologic response rates above 95% in patients who had hepatitis C virus (HCV) genotype 1 without cirrhosis, including those with HIV co-infection.
https://gastroenterology.acponline.org/archives/2017/03/24/7.htm
24 Mar 2017

Spotlight on statin therapy

Studies published in May found a potential benefit of statin therapy for three different conditions.
https://gastroenterology.acponline.org/archives/2017/05/26/5.htm
26 May 2017

Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response

A commentary in ACP Journal Club noted that while screening and treating all patients with chronic hepatitis C virus (HCV) would be cost-effective and probably cost-saving, some payers are still resistant.
https://gastroenterology.acponline.org/archives/2017/07/28/11.htm
28 Jul 2017

Result Page: Prev   1   2   3   4   Next